February 11, 2021 Background: The relationship of age and FIP incidence has been well discussed in the literature and has even been the topic of research [1]. Twenty-nine percent of FIP cases occurs in kittens under 0.5 years of age, Read more…
Updated January 23, 2021 Treatment with oral formulations of GS-441524 By Nicole Jacque, Niels C. Pedersen The initial field testing of GS-441524 for FIP treatment involved subcutaneous injection. This route of administration was based on prior pharmacokinetic (PK) studies done Read more…
This last year has been a milestone in our fight against FIP. We extended our landmark studies of 2018, when we published on a collaborative study with colleagues at Kansas State University on a drug called GC376. This was the Read more…
Dr. Pedersen has updated information about FIP in the “About FIP” category. Three additional articles entitled FIP Treatment, Black-Market Production and Sale of GS-441524 and GC376 and Neurological and ocular FIP have also been included in this same category. To Read more…
September 9, 2019 Dear owner of a cat with FIP: I am receiving many emails and phone calls regarding cats that are either being treated with GS-441524 with or without help from veterinarians or from owners that intend to start Read more…
Dr. Pedersen has updated the “FIP Treatment” article found in the “About FIP” category. There are two new articles posted in the “About FIP” category – one titled “Black-Market Production and Sale of GS-441524 and GC376” and the other titled “Neurological FIP”. To the numerous owners of cats with Read more…
They are no longer accepting cats for treatment. The two drugs that have been researched both show great promise. They are now in various stages of being commercialized. It could take one or two years before any of these drugs Read more…